Last update 19 Jul 2025

LV-232

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
LV 232, LV232
Target
HTR3 x SERT
Action
modulators
Mechanism
5-HT3 receptor modulators(5-hydroxytryptamine receptors, ionotropic (HTR3) modulators), Serotonin reuptake stimulants
Therapeutic Areas
Nervous System Diseases
Active Indication
Depressive Disorder, Major
Inactive Indication-
Originator Organization
Suzhou Vigonvita Life Sciences Co.,LtdSuzhou Vigonvita Life Sciences Co.,Ltd
Active Organization
Suzhou Vigonvita Life Sciences Co.,LtdSuzhou Vigonvita Life Sciences Co.,Ltd
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with LV-232
NCT06828887
/ RecruitingPhase 2
Multicenter,Randomized,Double-blind,Placebo,Parallel-controlled,Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of Major Depressive Disorder (MDD)
NCT06476509
/ CompletedPhase 1
A Non-Randomized, Open-Label, Exploratory Mechanistic Validation (PoM) Clinical Trial of LV232 Capsule Assessing Serotonin Transporter Occupancy in the Healthy Adult Brain Using 11C-DASB Positron Emission Tomography (PET)
NCT06279533
/ RecruitingPhase 1
Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules in Chinese Healthy Volunteers
100 Clinical Results associated with LV-232
Login to view more data
100 Translational Medicine associated with LV-232
Login to view more data
100 Patents (Medical) associated with LV-232
Login to view more data
100 Deals associated with LV-232
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Depressive Disorder, MajorPhase 2
China
Suzhou Vigonvita Life Sciences Co.,LtdSuzhou Vigonvita Life Sciences Co.,Ltd
03 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free